A new iridoid glycoside, buddlemacroside A (1) and 15 known compounds, including 6--L-(4-O-trans-p-coumaroyl)rhamnopyranosylcatalpol (2), 6--L-(2-caffeoyl)rhamnopyranosylcatalpol (3), salidroside (4), echipuroside A (5), darendoside A (6), decaffeoylacteoside (7), acteoside (8), martynoside (9), 8- (13), mimengoside C (14), buddlejasaponin Ia (15), and buddejasaponin I (16) were isolated from a methanol extract of the aerial parts of Buddleja macrostachya Benth. Their chemical structures were elucidated by extensive spectroscopic analyses, including MS and NMR spectra as well as by comparison with the data reported in the literature. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging test showed that compounds 3 and 7-9 possess significant scavenging capacity, with SC 50 values ranging from 6.9-19.6 µM. Compound 8 was shown to have potent inhibitory effect against the release of malondialdehyde (MDA) -the major product of the cellular lipid peroxidation, with IC 50 value of 2.3 µM. Compounds 12 and 16 significantly inhibited nitrite production in LPS-stimulated BV2 microglia, with IC 50 values of 14.2 and 11.4 µM, respectively. Furthermore, compound 16 showed cytotoxicity toward three human cancer cell lines, including SK-LU-1, MCF7, HepG2, with IC 50 values in the range of 6.5-8.0 µM.
Buddleja macrostachya Benth is a deciduous shrub belonging to the Buddlejaceae family. It grows up to six meters in height and flowers annually in December. It has a wide distribution, from China through India, Myanmar, Thailand, and Vietnam [1] . In the Chinese traditional medicine, the B. macrostachya flowers have been used to treat hepatitis, conjunctivitis, and keratitis [1] . In the Indian traditional medicine, its leaves have been used to treat bad sores and inflammation [2] . Although the Buddleja genus has been reported to produce many types of bioactive compounds, including iridoid [3] phenylethanoid glycoside [4] , flavonoid [5] , lignan [6] , and triterpenoid saponin [7] , little is known about the chemical constituents of B. macrostachya so far. In the present study, we report the isolation and structural elucidation 16 secondary metabolites, including one new iridoid glycoside, buddlemacroside A (1) and 14 known compounds from the methanol extract of the aerial parts of B. macrostachya ( Figure 1 ). In addition, the DPPH and MDA scavenging capacity, inhibitory effects on nitrite production, and cytotoxicity of the isolated compounds were also described.
Compound 1 was isolated as a dark yellow, amorphous powder. The molecular formula of 1 was established as C 39 19 carbons, including two olefinic carbons at  C 142.1 (C-3) and 103.7 (C-4), one hemiacetal carbon at  C 95.3 (C-1), one oxymethylene at  C 61.7 (C-10), two carbons of an epoxy group at  C 59.5 (C-7) and 66.4 (C-8), and two methine carbons at  C 37.3 (C-5) and 43.2 (C-9) were assignable to an iridoid nucleus [8] and 12 other signals were divided into one glucose and one rhamnose. Comparison of the 1 H and 13 C NMR data of 1 with those of the reported iridoid glycosides, [9] and picroside I [10] revealed a good agreement, suggesting that 1 is an iridoid glycoside bearing a trans-cinnamoyl and a trans-para-coumaroyl unit. Acid hydrolysis of 1 followed by GC analysis afforded D-glucose and L-rhamnose [11] .
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The planar chemical structure of 1 was then confirmed by HMBC and COSY experiment ( Figure 2 ). In the HMBC spectrum, HMBC correlations observed from δ H 4.83 (H-1) to δ C 95.3 (C-1) and from δ H 4.84 (H-1) to δ C 84.4 (C-6) indicated that the glucose and rhamnose are located at the C-1 and C-6 positions, respectively. The location of trans-cinnamoyl moiety at C-2 was determined by the HMBC correlation from  H 4.59/4.47 (H 2 -6) to a carbonyl carbon signal at  C 168.4 (C-9). The trans-para-coumaroyl moiety was located at C-3 through an ester linkage which was deduced by HMBC cross-peak from  H 5.10 (H-3) to  C 168.8 (C-9) and the COSY correlations between H-1 and H-2 and between H-2 and H-3. The relative configuration of 1 was determined by NOESY spectroscopic analysis ( Figure 2 ). In the NOESY spectrum, an NOE correlation between H-5 and H-9 was observed, suggesting that both protons are oriented to the same side of the molecule. H-6 showed an NOE cross-peak with H-1 and H-7 but not with H-9, while H-7 in turn correlated with H 3 -10 but not with H-5 and H-9, indicating that H-1, H-6, H-7, and H 3 -10 are located on the same face of the structure. Finally, the structure of 1 was established as 6- The known compounds, including: [8] , salidroside (4) [13] , echipuroside A (5) [14] , darendoside A (6) [15] , decaffeoylacteoside (7) [16] , acteoside (8) [17] , martynoside (9) 
[22], mimengoside C (14) [7] , buddlejasaponin Ia (15) [23] , and buddejasaponin I (16) [24] were identified by NMR spectroscopic analysis and comparing with the reported data in the literature. All the isolated compounds were evaluated for their antioxidant activity based on DPPH radical scavenging capacity [25] and inhibition of the release of malondialdehyde (MDA) -the major product of the cellular lipid peroxidation [26] . Among the compounds tested, compounds 3 and 7-9 showed significant DPPH scavenging capacity, with SC 50 values ranging from 6.9-19.6 µM, whereas 5 and 6 exhibited modest DPPH scavenging capacity ( In addition, the effects of the compounds on the nitrite production in LPS-stimulated BV2 microglia [27] and cytotoxicity toward SK-LU-1, MCF7, and HepG2 cancer cells were also assessed [28] ( Table 3 In conclusion, chemical investigation of the aerial parts of B. macrostachya resulted in the isolation and identification of 16 compounds, including a new iridoid glycoside, named buddlemacroside A. Evaluation of the DPPH scavenging activity revealed that compounds 3 and 7-9 could be considered as promising antioxidants. Compound 8 was also found to be a lipid peroxidation inhibitor, with potent MDA scavenging capacity. Furthermore, compounds 11 and 16 were shown to have in vitro anti-inflammatory effects as both compounds significantly inhibited the nitrite production in LPS-stimulated BV2 cells. Compound 16 was also found to be a promising anti-tumor agent, as it showed significant cytotoxicity against all three tested cancer cell lines, including SK-LU-1, MCF7, and HepG2 cells. The results of this study provide a scientific rationale for the therapeutic use of B. macrostachya and set a basis for the further development of antioxidant, anti-inflammatory, and anti-cancer products for the medical uses.
Experimental
General: Optical rotations, Jasco P-2000 digital polarimeter; NMR, Bruker AM500 FTNMR spectrometer; HR-ESI-MS, Agilent 6530 Accurate Mass Q-TOF LC/MS system. 
Extraction and isolation:
The dried aerial parts of B. macrostachya (1.8 kg) were ground and extracted with MeOH under sonication at room temperature. After concentration under reduced pressure, the MeOH extract (BM, 130 g) was suspended in water and partitioned with n-hexane, CH 2 Cl 2 , and EtOAc to give the n-hexane, CH 2 Cl 2 , EtOAc, and water soluble-fractions. The EtOAc fraction (BME) was subjected to fractionation over reversed phase (RP) C 18 Acid hydrolysis: Compound 1 was refluxed in 5% HCl at 80°C for 3 h. After drying in vacuo, the residues were partitioned between CH 2 Cl 2 and H 2 O. The aqueous layer was collected and dried in vacuo to give a residue. The residue was dissolved in anhydrous pyridine (100 mL) and mixed with a pyridine solution of 0.1 M Lcysteine methyl ester hydrochloride (100 mL) at 60°C for 2 h. A solution of trimethylsilylimidazole was then added and the reaction was incubated at 60°C for 2 h. The mixture was dried under reduced pressure and then partitioned between n-hexane and H 2 O. The nhexane layer was filtered and analyzed by GC. The absolute configurations of the monosaccharides were identified as D-glucose and L-rhamnose by comparing the retention times of persilylated monosaccharide derivatives with those of standard samples.
Supplementary data: HR-ESI-MS and NMR spectra of the new compound can be found in the online version.
